维波马患者的腹与第二个活性 (histidine isoleucine) 的同分泌有关,由单个编码基因解释
Lancet (London, England)
|November 19, 1983
概括
血管活性肠道 (VIP) 和西丁异黄素 (PHI) 是由VIPoma瘤共同产生的. 这一发现挑战了长期以来的信念,即单个神经元只能产生一个神经递质.
科学领域:
- 神经内分泌学神经内分泌学
- 分子生物学分子生物学
- 在瘤学瘤学.
背景情况:
- 胺西丁异氨酸 (PHI) 的分布与哺乳动物的血管活性肠 (VIP) 完全相同.
- 升高的VIP水平与一种内分泌瘤VIPoma有关.
研究的目的:
- 为了研究PHI和VIP在VIPoma患者中的共产.
- 为了确定PHI和VIP是否由VIP瘤中的相同细胞产生.
- 分析PHI和VIP联合制作的遗传基础.
主要方法:
- 在患者中测量血VIP和PHI类免疫活性.
- 对VIPoma组织进行免疫细胞化学分析.
- 来自瘤样本的信使RNA (mRNA) 测序.
主要成果:
- 患有VIPoma的患者始终表现出高水平的VIP和PHI类免疫活性.
- 免疫细胞化学证实,PHI和VIP是由同一细胞在VIPoma组织中产生的.
- 在同一个瘤内,mRNA分析揭示了VIP和PHI类的单独编码序列.
结论:
- 一个单细胞可以产生两个不同的调节,VIP和PHI,挑战一个神经递质-一个神经元学说.
- 在VIPoma中VIP和PHI的联合生产表明了调节的新机制.
- 这一发现对理解神经内分泌瘤生物学和神经元通信有重要意义.
更多相关视频
09:34Targeted Next-generation Sequencing and Bioinformatics Pipeline to Evaluate Genetic Determinants of Constitutional Disease
Published on: April 4, 2018
08:24Injections of Lipopolysaccharide into Mice to Mimic Entrance of Microbial-derived Products After Intestinal Barrier Breach
Published on: May 2, 2018
相关概念视频
Pleiotropy
Pleiotropy is the phenomenon in which a single gene impacts multiple, seemingly unrelated phenotypic traits. For example, defects in the SOX10 gene cause Waardenburg Syndrome Type 4, or WS4, which can cause defects in pigmentation, hearing impairments, and an absence of intestinal contractions necessary for elimination. This diversity of phenotypes results from the expression pattern of SOX10 in early embryonic and fetal development. SOX10 is found in neural crest cells that form melanocytes,...
Drugs for Treatment of Diarrhea-Predominant IBS
Diarrhea-predominant irritable bowel syndrome (IBS-D) is a subtype of IBS characterized primarily by frequent, loose, or watery stools, abdominal pain, and abdominal discomfort. Therapeutic approaches to managing IBS-D include dietary changes, stress management techniques, and pharmaceutical interventions.
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Two specific drugs used in the treatment are alosetron (Lotronex) and eluxadoline (Viberzi). Alosetron, a 5-HT3 antagonist, works by slowing the movement of stools in the gut, reducing bowel...
Irritable Bowel Syndrome I: Introduction
Irritable Bowel Syndrome (IBS) is characterized by functional disturbances in the gastrointestinal system, presenting a cluster of symptoms without evident structural or biochemical abnormalities. It primarily affects the large intestine and may cause abdominal pain, bloating, excessive gas, diarrhea, constipation, or both.
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
IBS is a chronic condition that can persist over a long period or recur frequently.
The pathogenesis of IBS involves a complex interplay of the following factors:
Altered...
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome II: Clinical Features and Diagnostic Evaluation
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Irritable Bowel Syndrome (IBS) is classified into subtypes based on the predominant bowel habits as determined by the Bristol Stool Form Scale (BSFS). The subtypes are:
Amebiasis
Entamoeba histolytica, a protozoan parasite, is responsible for intestinal and extraintestinal amebiasis. Though a significant proportion of infections remain asymptomatic, approximately 50 million individuals annually are estimated to present with clinical disease, resulting in up to 100,000 deaths globally. The disease burden is disproportionately high in regions with lower socioeconomic status, such as parts of India, Africa, Mexico, and Latin America.Etiology and TransmissionThe infective...
Irritable Bowel Syndrome
DefinitionIrritable bowel syndrome (IBS) is a functional gastrointestinal disorder characterized by recurrent combinations of abdominal pain, bloating, diarrhea, or constipation.Pathophysiology of irritable bowel syndromeIts pathophysiology is multifactorial, involving disturbances in motility, sensory processing, microbial balance, barrier integrity, and gut–brain communication. These mechanisms interact to produce symptoms that vary across IBS subtypes.Altered Motility PatternsDisordered...
